Endangered maritime archaeology in North Africa – the MarEA Project
Libyan Studies · 2023-11 · 54 · 135-150
DOI: 10.1017/lis.2023.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Libyan Studies, online erschienen am 12.07.2023. Verfasst von Julia Nikolaus und 2 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Increasing pressure – such as from conflict, climate change and urbanisation – on maritime cultural heritage in the Middle East and North Africa (MENA) led to the establishment of the Maritime Endangered Archaeology (MarEA) Project in 2019. This five-year programme aims to assess rapidly and comprehensively the vulnerability of maritime and coastal heritage in the MENA region and assist in its management in the face of the aforementioned challenges. The two case studies discussed in this article highlight some of the main aspects of MarEA's current work in North Africa by focusing on two different aspects of the methodological approach used: first, the generalised but comprehensive damage and threat assessment, as applied to all sites, and demonstrated for the historic port of Suakin (Sudan); second, site-specific shoreline change assessment for the purpose of assessing the impact of coastal erosion, as demonstrated for the World Heritage Site of Sabratha (Libya).
Zitieren
APA
Nikolaus, J., Westley, K., & Breen, C. (2023). Endangered maritime archaeology in North Africa – the MarEA Project. Libyan Studies, 54, 135-150. https://doi.org/10.1017/lis.2023.4
Vancouver
Nikolaus J, Westley K, Breen C. Endangered maritime archaeology in North Africa – the MarEA Project. Libyan Studies. 2023;54:135-150. doi:10.1017/lis.2023.4
BibTeX
@article{Nikolaus2023,
author = {Nikolaus, Julia and Westley, Kieran and Breen, Colin},
title = {Endangered maritime archaeology in North Africa – the MarEA Project},
journal = {Libyan Studies},
year = {2023},
volume = {54},
pages = {135--150},
doi = {10.1017/lis.2023.4}
}
EUVIMED